ARTHROSCOPIC SUBSCAPULARIS AUGMENTATION WITH XENOGRAFT GLENOID BONE BLOCK IN PATIENTS WITH RECURRENT ANTERIOR SHOULDER INSTABILITY

The use of a bone block enzymatically deantigenized in the treatment of patients with recurrent anterior shoulder instability

The purpose of this study was to investigate the clinical and radiographic outcomes at 2 years for patients who underwent an arthroscopic xenograft bone block procedure plus ASA for recurrent anteroinferior gleno-humeral instability. A bone block of equine origin and obtained through a patented enzymatic process was used. Twenty patients underwent arthroscopic xenograft bone block procedure and ASA. The mean preoperative Rowe score was 38.3 points, and it significantly improved (P < .001), increasing to 95.5 points. ROWE level at follow-up was excellent for 18 patients (90%), fair for 1 patient (5%), and poor for another patient (5%). The mean preoperative WOSI score was 1242 points, and it improved significantly (P <.0001), with a mean score of 120 points at follow-up. In all patients, the comparative study between CT scans performed postoperatively and at final follow-up did not reveal a volume reduction of the xenografts (P > .05) and absence areas affected by signs of resorption and breakage with 34.4% of postprocedural increase of the glenoid surface, were seen. The combination of ASA and bone block procedure with a xenograft was effective in the glenoid reconstruction and restoration of shoulder stability. No radiographic evidence of graft resorption, graft displacement, or glenohumeral arthritis were observed at 24-month follow-up.

PRODUCTS USED: OSTEOPLANT BONE BLOCK, OMC-80